Qiagen LLC Reagents and Consumables
ID: NIH-CC-OPC-25-000149Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/267c624ae028455a8c099d256e959b0a/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a firm fixed-price contract to Qiagen LLC for the procurement of reagent kits and consumables essential for isolating DNA and RNA from patients' blood samples. The reagents are critical for conducting tests related to hematological disorders and stem cell transplants, supporting both clinical care and research initiatives within the NIH's Department of Laboratory Medicine. This acquisition is being conducted under the Simplified Acquisition Procedures, allowing for a sole-source procurement due to the unique capabilities of Qiagen LLC's products, which have been fully validated for specific assays. Interested vendors capable of providing similar products are encouraged to submit capability statements to Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov by the specified deadline.

    Point(s) of Contact
    Kimala Winfield
    (301) 496-7015
    kimala.winfield@nih.gov
    Malinda Dehner
    (301) 594-6320
    dehnerm@cc.nih.gov
    Files
    Title
    Posted
    Attachment 1 List of Supplies 25-000149.docx
    The document lists supplies required for a government procurement, primarily focused on laboratory kits and consumables used in genetic testing and sample preparation. Key items include the ipsogen BCR-ABL1 Mbcr and JAK2 MutaQuant Kits, as well as various QIAsymphony DNA Mini and Midi Kits, highlighting a need for reliable molecular diagnostic tools. Additionally, it specifies filter-tips in multiple sizes and sample prep cartridges, indicating the intent to ensure precision in laboratory workflows. With the item numbers, quantities, and detailed descriptions, the document serves as a clear outline for vendors responding to a request for proposals (RFP). The focus on specific laboratory supplies reflects an overarching goal to support medical and research initiatives through accurate testing and analysis, underlining the government's commitment to public health and scientific advancement.
    Lifecycle
    Title
    Type
    Qiagen LLC Reagents and Consumables
    Currently viewing
    Presolicitation
    Similar Opportunities
    cDNA-PCR Sequencing Kits for long-read sequencing.
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of cDNA-PCR Sequencing Kits for long-read sequencing, as part of a combined synopsis/solicitation. The primary objective is to acquire Promethion Flow Cell packs and sequencing kits to support high-throughput sequencing efforts aimed at advancing research on neurodegenerative diseases, particularly Alzheimer's disease. This procurement is crucial for the Center for Alzheimer’s Disease and Related Dementias (CARD) and is expected to facilitate the identification of causative genes and potential therapeutic targets. Interested vendors must submit their quotations by 5:00 p.m. Eastern Time on December 30, 2024, referencing Solicitation Number 75N95025Q00008, and can direct inquiries to Iris Merscher at iris.merscher@nih.gov or by phone at 301-827-2547.
    In Vitro Biological Reagents
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole source procurement with Becton, Dickinson and Company for various in vitro biological reagents essential for research purposes. The procurement includes specific quantities of antibodies and reagents, such as Hu CD183 BV711 and Hu IL-13 BV421, along with shipping and handling to be delivered to Gaithersburg, Maryland. This procurement is justified under the authority of 41 U.S.C. 1901 (a)(1), indicating that only one responsible source can meet the agency's requirements. Interested parties may submit a capability statement via the NIAID electronic Simplified Acquisition Submission System (eSASS) by December 30, 2024, with all submissions considered at the Government's discretion. For further inquiries, contact Leah Hinson at leah.hinson@nih.gov.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), intends to award a non-competitive contract to Illumina, Inc. for the supply of "Illumina Reagents and Consumables" essential for various sequencing and genotyping systems. This procurement is driven by the unique operational needs of NIH-owned systems, as confirmed by market research indicating that only Illumina can provide the proprietary reagents necessary to maintain research integrity and support ongoing studies. The contract performance period is set from September 3, 2025, to September 2, 2030, and interested parties may submit capability statements for review by January 6, 2025; however, this is not a solicitation for proposals. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or by phone at +1 301 496 2153.
    Long Sequencing Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) NIDA, is seeking qualified small businesses to provide Long Sequencing Kits as part of a Sources Sought notice. The primary objective of this procurement is to acquire kits that facilitate long read sequencing for analyzing biomarkers related to Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD), which are crucial for understanding disease progression and therapeutic efficacy. The kits must meet specific technical requirements, including compatibility with Nanopore PromethION 48 sequencers and the ability to generate substantial sequencing data in real-time. Interested parties must submit their capability statements to Andrea Clay at amcgee@nida.nih.gov by December 31, 2024, at 12:00 PM Eastern Time, as this notice is strictly for research and information purposes and does not obligate the government to award a contract.
    Assay Kits for Lumipulse instrument
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of assay kits for the Lumipulse instrument, aimed at quantifying specific biomarkers related to Alzheimer's Disease. The acquisition includes a total of 4,410 assays for biomarkers abeta42, abeta40, and pTau 217, which will be utilized in research involving stored samples from the Baltimore Longitudinal Study of Aging (BLSA) to assess cognitive decline and neurodegeneration. This procurement is critical for advancing Alzheimer’s research and will be awarded as a firm fixed-price purchase order, with quotations due by 5:00 p.m. Eastern Time on January 8, 2025. Interested vendors should contact Iris Merscher at iris.merscher@nih.gov for further details.
    6550--RFI: NOI SS Reagents for BioFire Analyzer
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a Special Notice for a Sole Source contract to procure reagents for the BioFire Analyzer from BIOMERIEUX INC. This contract, structured as a Firm-Fixed Price delivery order, will span one year and is intended to support the medical needs of the Michael E. DeBakey VA Medical Center in Houston, Texas. The reagents are critical for in vitro diagnostics, ensuring safe handling and timely reporting in compliance with VA regulations. Interested vendors are encouraged to submit information regarding their capabilities by the specified deadline, and inquiries can be directed to Contracting Officer Shasta Britt at shasta.britt@va.gov or by phone at 713-794-8609.
    Werfen USA LLC Various Consumables and lease of two ACL Top 750 Instruments for the Department of Laboratory Medicine at the NIH Clinical Center
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a firm fixed price purchase order to Werfen USA LLC for various consumables and the lease of two ACL Top 750 instruments for the Department of Laboratory Medicine at the NIH Clinical Center. This acquisition aims to extend the lease of the ACL TOP 750 analyzers, which are critical for conducting routine and specialized coagulation tests in mid to high-volume clinical laboratories, enhancing lab efficiency and result reliability. Interested parties may submit their capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by December 27, 2024, 6:30 AM EST, with the total contract value not exceeding $250,000, as this procurement is being conducted under Simplified Acquisition Procedures.
    Qiagen Laboratory Equipment Preventative Maintenance
    Active
    Dept Of Defense
    The Department of Defense, through the United States Army Research Acquisition Activity (USAMRAA), intends to negotiate a sole-source contract with QIAGEN for preventative maintenance and technical support services for three QIAGEN EZ1 Advanced XL automated nucleic acid systems located in Silver Spring, Maryland. The procurement requires specialized knowledge for molecular calibrations and proprietary technical support, which only QIAGEN can provide due to their unique expertise and capabilities. Interested parties must submit their qualifications in writing to Mr. Keith C. Crum at keith.c.crum.civ@health.mil, as this notice serves as the only announcement and a written solicitation will not be issued. Responses must be received by the specified deadline to be considered, and the NAICS code for this opportunity is 811210, with a size standard of $30 million.
    Global Life Sciences Solutions Preventative Maintenance Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract for preventative maintenance services for three Sepax Pro Cell Processing Systems used in cell therapy manufacturing and research. The contract will be awarded to Global Life Sciences Solutions USA LLC, the only vendor authorized to perform these services due to the proprietary nature of the equipment and the requirement for compliance with FDA regulations regarding critical equipment maintenance. The period of performance for this contract is set from January 27, 2025, to January 26, 2026, with interested parties encouraged to submit capability statements by December 28, 2024, to Sheri Eiri at sheri.eiri@nih.gov for consideration.
    CHROMIUM IX/X AND VISIUM CYTASSIT ASSURANCE PLAN
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to negotiate a sole-source contract with 10X Genomics, Inc. for a warranty and maintenance agreement for their Chromium X and CytAssist instruments. This procurement is critical as these instruments are essential for conducting advanced single-cell sequencing and spatial transcriptomics research, which supports the development of new diagnostics, therapeutics, and vaccines against human diseases. The maintenance agreement will ensure uninterrupted operation of these technologies, which are vital for NIAID researchers, and interested vendors must submit their capabilities statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by 12:00 PM EST on December 30, 2024. For further inquiries, vendors can contact Maliaka Pinkney at maliaka.pinkney@nih.gov or Jesse D. Weidow at weidowjd@niaid.nih.gov.